Characterization of immune cell infiltrate in tumor stroma and epithelial compartments in oral squamous cell carcinomas of Sudanese patients
Open Access
- 9 October 2021
- journal article
- research article
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 8 (1) , 130-140
Abstract
Background: Tumor immune infiltrate has been explored in oral squamous cell carcinoma (OSCC), but studies on simultaneous characterization of multiple immune cell subtypes separately in stromal and intraepithelial tumor compartments are limited.Objectives: We aimed to investigate the immune cell infiltrate in OSCC by using immunohistochemistry (IHC) for a panel of inflammatory cells in stromal and epithelial tumor compartments for a better characterization of the tumors.Methods: Thirty‐six OSCC lesions and nine normal oral mucosa (NOM) samples from patients attending Khartoum Dental Teaching Hospital, Sudan were investigated for presence of tumor infiltrating lymphocytes, tumor‐associated macrophages, tumor‐associated neutrophils, and PD‐L1 positive cells in the inflammatory infiltrate by single and double IHC. Digital quantitative analysis (Aperio Technologies Inc.) was performed separately for stromal and epithelial compartments.Results: OSCC cases displayed a higher inflammatory infiltrate in the associated stroma, but not in the epithelial compartment when compared to NOM. The immunosuppressive type of inflammatory infiltrate, that is, T regulatory cells (FoxP3+ cells) was identified to be significantly higher in the epithelial compartment of tumors with advanced clinical state. An immunoscore developed by combining intraepithelial FoxP3+ and CD4+ cells was found significantly higher in lesions from elderly patients, localized at toombak dipping‐related sites, poorly differentiated OSCCs, or with loco‐regional lymph node spreading.Conclusions: Despite heavy immune cell infiltration in tumor‐associated stroma, the majority of OSCCs in this cohort displayed a low intraepithelial immune infiltration. An immunoscore based on combined CD4 and FoxP3 intraepithelial expression may serve as an indicator of advanced tumor progression and should be further investigated for its use as potential prognostic biomarker in OSCC.Keywords
Funding Information
- Direktoratet for internasjonalisering og kvalitetsutvikling i høgare utdanning (NORPART‐2018/10277)
- Helse Vest (911902/2013, 912260/2019)
- Norges Forskningsråd (22325)
This publication has 32 references indexed in Scilit:
- Cancer incidence in Khartoum, Sudan: first results from the Cancer Registry, 2009–2010Cancer Medicine, 2014
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumoursThe Journal of Pathology, 2013
- Successful triple immunoenzymatic method employing primary antibodies from same species and same immunoglobulin subclassEuropean Journal of Histochemistry, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- T regulatory cell markers in oral squamous cell carcinoma: Relationship with survival and tumor aggressivenessOncology Letters, 2010
- Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinomaBMC Cancer, 2009
- Intratumoral rhIL‐12 administration in head and neck squamous cell carcinoma patients induces B cell activationInternational Journal of Cancer, 2008
- Metastasis of squamous cell carcinoma of the oral tongueCancer and Metastasis Reviews, 2007
- Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic valueThe Journal of Pathology, 1992
- New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomasJournal of Oral Pathology & Medicine, 1989